Healthcare provider profile · identity verified

Sol A Robles, MD

General Practice · LUQUILLO, PR · NPI 1326036294

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	234	62
Simvastatin	Simvastatin	202	78
Glipizide	Glipizide	172	33
Losartan Potassium	Losartan Potassium	172	62
Metformin Hcl	Metformin Hcl	163	38
Omeprazole	Omeprazole	149	66
Amlodipine Besylate	Amlodipine Besylate	120	36
Atorvastatin Calcium	Atorvastatin Calcium	112	41
Levothyroxine Sodium	Levothyroxine Sodium	110	39
Tamsulosin Hcl	Tamsulosin Hcl	104	37
Diclofenac Potassium	Diclofenac Potassium	87	42
Metoprolol Tartrate	Metoprolol Tartrate	86	24
Diclofenac Sodium	Diclofenac Sodium	85	45
Famotidine	Famotidine	80	26
Nabumetone	Nabumetone	77	35
Enalapril Maleate	Enalapril Maleate	75	15
Temazepam	Temazepam	74	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	74	47
Tramadol Hcl	Tramadol Hcl	69	suppressed
Clonazepam	Clonazepam	67	14
Azithromycin	Azithromycin	65	51
Lisinopril	Lisinopril	65	28
Montelukast Sodium	Montelukast Sodium	62	21
Pantoprazole Sodium	Pantoprazole Sodium	61	18
Finasteride	Finasteride	60	23
Furosemide	Furosemide	52	19
Clopidogrel	Clopidogrel Bisulfate	50	16
Alprazolam	Alprazolam	45	11
Hydrochlorothiazide	Hydrochlorothiazide	43	16
Synthroid	Levothyroxine Sodium	43	17
Carvedilol	Carvedilol	42	suppressed
Albuterol Sulfate	Albuterol Sulfate	39	20
Levofloxacin	Levofloxacin	39	32
Lorazepam	Lorazepam	39	suppressed
Meclizine Hcl	Meclizine Hcl	37	18
Irbesartan	Irbesartan	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	13
Betamethasone Valerate	Betamethasone Valerate	29	25
Fluticasone Propionate	Fluticasone Propionate	29	12
Sertraline Hcl	Sertraline Hcl	29	suppressed
Atenolol	Atenolol	28	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	28	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	28	suppressed
Mupirocin	Mupirocin	27	21
Pentoxifylline	Pentoxifylline	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Metoprolol Succinate	Metoprolol Succinate	21	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	21	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	20	11
Donepezil Hcl	Donepezil Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Ibuprofen	Ibuprofen	19	11
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	12
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Humalog	Insulin Lispro	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Ampicillin Trihydrate	Ampicillin Trihydrate	16	16
Captopril	Captopril	16	suppressed
Eliquis	Apixaban	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Dexamethasone	Dexamethasone	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Estazolam	Estazolam	12	suppressed
Naproxen	Naproxen	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error